ENFLONSIA is a long-acting monoclonal antibody designed to shield infants through a typical five-month RSV season with a single, fixed dose
The event marks a significant push into South Korea’s rapidly expanding bio-health ecosystem
The upgrade centres on new machinery and advanced technology designed to expand capacity and sharpen turnaround times in increasingly competitive flexible packaging markets.
Policy, regulations, AI and CRDMO take centre stage at the flagship event of the Department of Pharmaceuticals
Novo Nordisk continues to position Wegovy as a cornerstone of its obesity treatment portfolio
The dual expansion simplifies transcriptomics workflows by combining faster regional turnaround with easier sample logistics
The new device promises faster, more efficient cardiac procedures while maintaining the safety and effectiveness clinicians expect
The data will be presented at the 2026 European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Global Congress in Munich, April 17-21
Chronic GVHD is a serious and potentially life-threatening condition, imposing profound physical and emotional burdens on a substantial proportion of patients following allogeneic stem cell transplantation
The drug meets all primary endpoints across 608 patients in Europe and India, strengthening the company's biosimilars pipeline
Subscribe To Our Newsletter & Stay Updated
